Reports cite cardiovascular risks of COX 2 inhibitors and NSAIDsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7568.565-a (Published 14 September 2006) Cite this as: BMJ 2006;333:565
- Janice Hopkins Tanne
- New York
Cyclo-oxygenase-2 (COX 2) inhibitors and some other non-steroidal anti-inflammatory drugs (NSAIDs) may present cardiovascular and renal risks, say two papers published online ahead of print publication in JAMA.
And an accompanying editorial by David Graham, a Food and Drug Administration employee and whistleblower, criticises studies of COX …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial